Decision
MHRA statement on products containing cannabidiol (CBD)
The Medicines and Healthcare products Regulatory Agency opinion on the regulatory status of products containing CBD.
Documents
Details
Products containing cannabidiol (CBD) used for medical purposes are medicines. If a company markets a CBD containing product that makes a medicinal claim it will be considered to fall within the definition of a medical product contained in The Human Medicines Regulations 2012.
Updates to this page
Published 14 April 2025